MAUI LAND & PINEAPPLE CO (MLP) Fundamental Analysis & Valuation

NYSE:MLP • US5773451019

16.42 USD
-0.32 (-1.91%)
Last: Mar 6, 2026, 01:35 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MLP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall MLP gets a fundamental rating of 2 out of 10. We evaluated MLP against 63 industry peers in the Real Estate Management & Development industry. MLP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MLP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. MLP Profitability Analysis

1.1 Basic Checks

  • In the past year MLP has reported negative net income.
  • In the past year MLP has reported a negative cash flow from operations.
  • MLP had negative earnings in 4 of the past 5 years.
  • Of the past 5 years MLP 4 years had a positive operating cash flow.
MLP Yearly Net Income VS EBIT VS OCF VS FCFMLP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • With a Return On Assets value of -24.66%, MLP is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
  • MLP's Return On Equity of -33.53% is on the low side compared to the rest of the industry. MLP is outperformed by 68.25% of its industry peers.
Industry RankSector Rank
ROA -24.66%
ROE -33.53%
ROIC N/A
ROA(3y)-5.93%
ROA(5y)-6.7%
ROE(3y)-8.61%
ROE(5y)-10.63%
ROIC(3y)N/A
ROIC(5y)N/A
MLP Yearly ROA, ROE, ROICMLP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

1.3 Margins

  • MLP has a better Gross Margin (30.62%) than 61.90% of its industry peers.
  • MLP's Gross Margin has declined in the last couple of years.
  • MLP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.4%
GM growth 5Y-5.65%
MLP Yearly Profit, Operating, Gross MarginsMLP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MLP Health Analysis

2.1 Basic Checks

  • MLP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MLP has been increased compared to 1 year ago.
  • The number of shares outstanding for MLP has been increased compared to 5 years ago.
  • The debt/assets ratio for MLP is higher compared to a year ago.
MLP Yearly Shares OutstandingMLP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MLP Yearly Total Debt VS Total AssetsMLP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • MLP has an Altman-Z score of 14.35. This indicates that MLP is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 14.35, MLP belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • A Debt/Equity ratio of 0.09 indicates that MLP is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.09, MLP is doing good in the industry, outperforming 73.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z 14.35
ROIC/WACCN/A
WACC8.71%
MLP Yearly LT Debt VS Equity VS FCFMLP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.38 indicates that MLP should not have too much problems paying its short term obligations.
  • MLP has a Current ratio (1.38) which is comparable to the rest of the industry.
  • MLP has a Quick Ratio of 1.38. This is a normal value and indicates that MLP is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.38, MLP perfoms like the industry average, outperforming 46.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 1.38
MLP Yearly Current Assets VS Current LiabilitesMLP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MLP Growth Analysis

3.1 Past

  • MLP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -126.92%.
  • The Revenue has grown by 50.36% in the past year. This is a very strong growth!
  • The Revenue has been growing slightly by 2.95% on average over the past years.
EPS 1Y (TTM)-126.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.39%
Revenue 1Y (TTM)50.36%
Revenue growth 3Y-2.3%
Revenue growth 5Y2.95%
Sales Q2Q%49.44%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MLP Yearly Revenue VS EstimatesMLP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

0

4. MLP Valuation Analysis

4.1 Price/Earnings Ratio

  • MLP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MLP Price Earnings VS Forward Price EarningsMLP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLP Per share dataMLP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MLP Dividend Analysis

5.1 Amount

  • MLP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MLP Fundamentals: All Metrics, Ratios and Statistics

MAUI LAND & PINEAPPLE CO

NYSE:MLP (3/6/2026, 1:35:37 PM)

16.42

-0.32 (-1.91%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)11-12
Earnings (Next)03-30
Inst Owners28.02%
Inst Owner Change-3.37%
Ins Owners66.03%
Ins Owner Change2.03%
Market Cap324.13M
Revenue(TTM)18.34M
Net Income(TTM)-11.31M
Analysts80
Price TargetN/A
Short Float %2.43%
Short Ratio8.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.67
P/FCF N/A
P/OCF N/A
P/B 9.61
P/tB 9.61
EV/EBITDA N/A
EPS(TTM)-0.57
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0.93
BVpS1.71
TBVpS1.71
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.66%
ROE -33.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.62%
FCFM N/A
ROA(3y)-5.93%
ROA(5y)-6.7%
ROE(3y)-8.61%
ROE(5y)-10.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.4%
GM growth 5Y-5.65%
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 1.38
Altman-Z 14.35
F-Score3
WACC8.71%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)7.61%
Cap/Sales(5y)4.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-126.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%110.39%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)50.36%
Revenue growth 3Y-2.3%
Revenue growth 5Y2.95%
Sales Q2Q%49.44%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y127.01%
OCF growth 3Y-35.67%
OCF growth 5Y-26.88%

MAUI LAND & PINEAPPLE CO / MLP FAQ

What is the fundamental rating for MLP stock?

ChartMill assigns a fundamental rating of 2 / 10 to MLP.


Can you provide the valuation status for MAUI LAND & PINEAPPLE CO?

ChartMill assigns a valuation rating of 0 / 10 to MAUI LAND & PINEAPPLE CO (MLP). This can be considered as Overvalued.


What is the profitability of MLP stock?

MAUI LAND & PINEAPPLE CO (MLP) has a profitability rating of 1 / 10.


Can you provide the financial health for MLP stock?

The financial health rating of MAUI LAND & PINEAPPLE CO (MLP) is 4 / 10.